User: Guest  Login
Less Searchfields
Simple search
Title:

SGNLVA-002: Single arm, open-label, phase Ib/II study of ladiratuzumab vedotin (LV) in combination with pembrolizumab for first-line treatment of triple-negative breast cancer

Document type:
Meeting Abstract
Author(s):
Cortes, J.; Diab, S.; Basho, R. K.; Oliveira, M.; Pluard, T.; Alemany, C.; Brown-Glaberman, U.; Meisel, J.; Boni, V.; Sinha, R.; Garcia Estevez, L.; Ettl, J.; Kuemmel, S.; Manso Sanchez, L. M.; Moon, Y. W.; Villanueva Vazquez, R.; Wuerstlein, R.; Wang, Y.; Wang, Z.; Han, H.
Journal title abbreviation:
Ann Oncol
Year:
2020
Journal volume:
31 Suppl 4
Pages contribution:
S393-S393
Fulltext / DOI:
doi:10.1016/j.annonc.2020.08.459
Print-ISSN:
0923-7534
TUM Institution:
Frauenklinik und Poliklinik
 BibTeX